CytomX Therapeutics stock price
사이톰엑스 테라퓨틱스NASDAQ:CTMX · Nasdaq · HealthcareToday's signals · No active technical signal.
Signal details →CytomX Therapeutics last closed at $2.56 (-2.66%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -7.0×. Its overall grade ranks 506 of 739 stocks in Healthcare.
About this company
CytomX Therapeutics last closed at $2.56 (-2.66%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 506/739
Valuation grade B+
Related stocks
- Bristol Myers SquibbCustomer
CytomX의 항체-약물 접합체 및 면역항암제 파이프라인과 협업·라이선스 경험이 있는 대형 제약사
- AmgenCustomer
CytomX의 프로바디(Probody) 기반 항암제 후보와 협력한 주요 글로벌 파트너
- AstraZenecaCustomer
CytomX의 종양 표적 치료제 플랫폼과 협업한 글로벌 제약사
About CytomX Therapeutics
- What technical signals does CytomX Therapeutics (CTMX) have?
- CytomX Therapeutics current technical signals: no active technical signal.
- Is CytomX Therapeutics a cup-and-handle pattern?
- No. CytomX Therapeutics has no valid Cup signal right now.
- What published figures are available for CytomX Therapeutics?
- Market cap: $433.75M. Trailing 12 months PER: -7.0×. Latest quarter PBR: 1.86×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about CytomX Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.